Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Veterinary use  





2 Pharmacology  





3 Legal status  





4 See also  





5 References  





6 External links  














Etorphine






Dansk
Deutsch
Español
فارسی
Français
Hrvatski
Italiano

Polski
Português
Română
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Svenska
Türkçe
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Etorphine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • BR: Class F1 (Prohibited narcotics)
  • CA: Schedule I
  • DE: Anlage III (Special prescription form required)
  • UK: Class A
  • US: Schedule I and Schedule II
  • UN: Narcotic Schedules I and IV
  • EU: List I (Netherlands)
  • Identifiers
    • (5α,6β,14β,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-7,8-didehydro-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol

    CAS Number
    PubChem CID
    IUPHAR/BPS
    DrugBank
    ChemSpider
    UNII
    KEGG
    ChEBI
    ChEMBL
    CompTox Dashboard (EPA)
    ECHA InfoCard100.035.017 Edit this at Wikidata
    Chemical and physical data
    FormulaC25H33NO4
    Molar mass411.542 g·mol−1
    3D model (JSmol)
    • C[C@](CCC)(O)[C@H]1C[C@]23C=C[C@]1(OC)[C@@H]4Oc5c(O)ccc6C[C@H]2N(C)CC[C@]43c65

    • InChI=1S/C25H33NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,9-10,17-18,21,27-28H,5,8,11-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1 checkY

    • Key:CAHCBJPUTCKATP-FAWZKKEFSA-N checkY

     ☒NcheckY (what is this?)  (verify)

    Etorphine (M99) is a semi-synthetic opioid possessing an analgesic potency approximately 1,000–3,000 times that of morphine.[1] It was first prepared in 1960 from oripavine, which does not generally occur in opium poppy extract but rather the related plants Papaver orientale and Papaver bracteatum.[2] It was later reproduced in 1963 by a research group at MacFarlan SmithinGorgie, Edinburgh, led by Kenneth Bentley.[3] It can also be produced from thebaine.[4]

    Veterinary use[edit]

    Etorphine is available legally only for veterinary use and is strictly governed by law. It is often used to immobilize elephants and other large mammals. Diprenorphine (Revivon) is an opioid receptor antagonist that can be administered in proportion to the amount of etorphine used (1.3 times) to reverse its effects. Veterinary-strength etorphine is fatal to humans. For this reason the package as supplied to vets always includes the human antidote along with the etorphine.

    The human antidote is generally naloxone, not diprenorphine, and is always prepared before the preparation of etorphine to be immediately administered following accidental human exposure to etorphine. The LD50 in humans is 3 μg which led to the requirement that the medicine include an equal dose of an antidote, diprenorphineornaloxone.

    One of its main advantages is its speed of operation, and more importantly, the speed that diprenorphine reverses its effects. The high incidence of side effects, including severe cardiopulmonary depression, has caused etorphine to fall into disfavor in general veterinary practice. However, its high potency, combined with the rapid action of both etorphine and its antagonist, diprenorphine, means that it has found a place for use in the capture of large mammals such as rhinoceroses and elephants, where rapid onset and rapid recovery are both very important. The high potency of etorphine means that sufficient etorphine can be administered to large wild mammals by projectile syringe (dart).

    Large Animal Immobilon is a combination of etorphine plus acepromazine maleate. An etorphine antidote Large Animal Revivon contains mainly diprenorphine for animals and a human-specific naloxone-based antidote, which should be prepared prior to the etorphine. A 5–15 mg dose is enough to immobilize an African elephant and a 2–4 mg dose is enough to immobilize a black rhinoceros.[5]

    Pharmacology[edit]

    Etorphine is an extremely potent, non-selective full agonist of the μ-, δ-, and κ-opioid receptors.[6][7] It also has relatively weak affinity for the nociceptin receptor.[8] Etorphine has an LD50 of 3 μg in humans.[9]

    Legal status[edit]

    InHong Kong, etorphine is regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. It can be used legally only by health professionals and for university research purposes. The substance can be given by pharmacists under a prescription. Anyone who supplies the substance without prescription can be fined $10,000 (HKD). The penalty for trafficking or manufacturing the substance is a $5,000,000 (HKD) fine and life imprisonment. Possession of the substance for consumption without license from the Department of Health is illegal with a $1,000,000 (HKD) fine and/or 7 years of jail time.[10]

    In the Netherlands, etorphine is a Schedule I drug of the Opium Law. It is used only for veterinary purposes in zoos to immobilize large animals.[11]

    In the US, etorphine is listed as a Schedule I drug with an ACSCN of 9056, although its hydrochloride salt is classified as Schedule II with an ACSCN of 9059.[12] The 2013 annual aggregate manufacturing quota for both was zero so veterinary supplies of the hydrochloride are presumably imported from Germany and/or the UK. [citation needed]

    In the UK, under the Misuse of Drugs Act 1971, etorphine is controlled as a Class A substance.[13]

    In Italy Etorphine is illegal, as are the parent compounds Dihydroetorphine and Acetorphine. (Datas from 2022)[14]

    See also[edit]

    References[edit]

    1. ^ Bentley KW, Hardy DG (June 1967). "Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine". Journal of the American Chemical Society. 89 (13): 3281–3292. doi:10.1021/ja00989a032. PMID 6042764.
  • ^ Aggrawal A (1995). "Chapter 3 Opium: the king of narcotics". Narcotic Drugs. New Delhi: National Book Trust. pp. xvi+161. ISBN 81-237-1383-5.
  • ^ Bentley KW, Hardy DG (1963). "New potent analgesics in the morphine series". Proceedings of the Chemical Society. 220: 189–228. doi:10.1039/PS9630000189.
  • ^ Huang XR, Srimurugan S, Lee GH, Chen C (February 2011). "A Facile Synthesis and Structural Verification of Etorphine and Dihydroetorphine from Codeine". Journal of the Chinese Chemical Society. 58 (1): 101–107. doi:10.1002/jccs.201190048. ISSN 0009-4536.
  • ^ "Etorphine HCl". Veterinary medicine for wildlife: immobilisation medicine for animals zoo animals. Zoo Pharm. Archived from the original on 2016-09-08. Retrieved 2013-10-11.
  • ^ Pasternak G (17 April 2013). The Opiate Receptors. Springer Science & Business Media. pp. 444–. ISBN 978-1-60761-990-1.
  • ^ Gharagozlou P, Hashemi E, DeLorey TM, Clark JD, Lameh J (January 2006). "Pharmacological profiles of opioid ligands at kappa opioid receptors". BMC Pharmacology. 6 (1): 3. doi:10.1186/1471-2210-6-3. PMC 1403760. PMID 16433932.
  • ^ Hawkinson JE, Acosta-Burruel M, Espitia SA (February 2000). "Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors". European Journal of Pharmacology. 389 (2–3): 107–114. doi:10.1016/S0014-2999(99)00904-8. PMID 10688973.
  • ^ Riviere JE, Papich MG (2009-03-17). Riviere JE, Papich MG (eds.). Veterinary Pharmacology and Therapeutics. John Wiley & Sons. p. 32. ISBN 978-0-8138-2061-3.
  • ^ "Hong Kong e-Legislation". www.elegislation.gov.hk. Retrieved 2022-03-30.
  • ^ "Opiumwet". Ministerie van Binnenlandse Zaken en Koninkrijksrelaties (in Dutch). Retrieved 2022-03-30.
  • ^ "Etorphine". PubChem. U.S. National Library of Medicine. CID 26721. Retrieved 2022-03-30.
  • ^ "List of most commonly encountered drugs currently controlled under the misuse of drugs legislation". GOV.UK. Retrieved 2022-03-30.
  • ^ "Tabelle delle sostanze stupefacenti e psicotrope". Ministero della Salute (in Italian). Retrieved 2022-04-09.
  • External links[edit]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Etorphine&oldid=1219443483"

    Categories: 
    Analgesics
    Delta-opioid receptor agonists
    4,5-Epoxymorphinans
    Ethers
    Semisynthetic opioids
    Kappa-opioid receptor agonists
    Mu-opioid receptor agonists
    Nociceptin receptor agonists
    Phenols
    Tertiary alcohols
    Hidden categories: 
    CS1 Dutch-language sources (nl)
    CS1 Italian-language sources (it)
    Articles with short description
    Short description is different from Wikidata
    Drugs with non-standard legal status
    Articles with changed CASNo identifier
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All articles with unsourced statements
    Articles with unsourced statements from August 2022
     



    This page was last edited on 17 April 2024, at 19:57 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki